Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Samantha Lindsay Kass"'
Autor:
Marc Ladanyi, Justin F. Gainor, Alice T. Shaw, Ronglai Shen, Samantha Lindsay Kass, Gregory J. Riely, Helena A. Yu, Leora Horn, Christine A. Lydon, Geoffrey R. Oxnard, Jonathan Aston, Christine M. Lovly, Wade T. Iams, Mark G. Kris, Camelia S. Sima, Megan L. Hames
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(3)
Background We previously demonstrated that patients with metastatic KRAS mutant lung cancers have a shorter survival compared with patients with KRAS wild-type cancers. Recent reports have suggested different clinical outcomes and distinct activated
Autor:
Binsheng Zhao, Camelia S. Sima, Kai Hsiung Lin, Dyana K. Sumner, Michelle S. Ginsberg, Lauren J. Rogak, M. Catherine Pietanza, Alison Berkowitz-Hergianto, Marwan Shouery, Samantha Lindsay Kass, Mark G. Kris, Ethan Basch, Aaron Gabow, Mary Shaw, Lawrence H. Schwartz, Alex E. Lash, Manda Wilson, Marcia Latif, Leslie B. Tyson, Qinfei Wu, Claire Miller
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(16)
Purpose In clinical trials, traditional monitoring methods, paper documentation, and outdated collection systems lead to inaccuracies of study information and inefficiencies in the process. Integrated electronic systems offer an opportunity to collec
Autor:
William Pao, Vincent A. Miller, Christopher G. Azzoli, Camelia S. Sima, Maria E. Arcila, Mark G. Kris, Yelena Y. Janjigian, Marc Ladanyi, Samantha Lindsay Kass, Gregory J. Riely, Geoffrey R. Oxnard
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 17(19)
Purpose: Given the unprecedented efficacy of EGFR tyrosine kinase inhibitors (TKI) in advanced EGFR-mutant lung cancer, adjuvant TKI therapy is an appealing strategy. However, there are conflicting findings regarding the potential benefit of adjuvant
Autor:
Mark G. Kris, Samantha Lindsay Kass, Camelia S. Sima, Helena Alexandra Yu, Ronglai Shen, Gregory J. Riely, Marc Ladanyi
Publikováno v:
Journal of Clinical Oncology. 31:8025-8025
8025 Background: Patients (pts) with KRAS mutant lung cancers have a shorter survival compared to pts with KRAS/EGFR wild type tumors (Johnson et al, Cancer 2012). Whether outcomes for patients with KRAS mutant metastatic lung cancers differ by smoki
Autor:
Aaron Gabow, Samantha Lindsay Kass, Ethan Basch, Quinfei Wu, Manda Wilson, Camelia S. Sima, Marwan Shouery, Marcia Latif, Claire Miller, Leslie B. Tyson, Lawrence H. Schwartz, Michelle S. Ginsberg, Mark G. Kris, Dyana K. Sumner, Lauren J. Rogak, Maria Catherine Pietanza, Alex E. Lash, Mary Shaw, Binsheng Zhao, Alison Berkowitz
Publikováno v:
Journal of Clinical Oncology. 30:e19647-e19647
e19647 Background: In clinical trials, delayed and disorganized data reporting due to traditional toxicity symptom monitoring methods, paper documentation and out-dated collection systems lead to inaccuracies of critical study information and ineffic